Modified Factor IX polypeptides and uses thereof

Details for Australian Patent Application No. 2009244633 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft Bayer HealthCare LLC

Inventors Haupts, Ulrich; Seto, Marian; Patel, Chandra; Murphy, John E.; Gritzan, Uwe; Jiang, Xiaoqiao; Kirchner, Kornelia; Brooks, Alan

Agent Davies Collison Cave

Pub. Number AU-A-2009244633

PCT Pub. Number WO2009/137254

Priority 61/124,567 16.04.08 US; 61/045,961 17.04.08 US

Filing date 16 April 2009

Wipo publication date 12 November 2009

International Classifications

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/137254 Priority application(s): WO2009/137254

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244634-Method for evaluating and comparing immunorepertoires

2009244627-Methods for producing a log of material properties